- NEWS AND VIEWS
Promising reversible protein inhibitors kept on target
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 603, 583-584 (2022)
doi: https://doi.org/10.1038/d41586-022-00692-5
References
Singh, J., Petter, R. C., Baillie, T. A. & Whitty, A. Nature Rev. Drug. Discov. 10, 307–317 (2011).
De Vita, E. Future Med. Chem. 13, 193–210 (2021).
Reja, R. M., Wang, W., Lyu, Y., Haeffner, F. & Gao, J. J. Am. Chem. Soc. 144, 1152–1157 (2022).
Serafimova, I. M. et al. Nature Chem. Biol. 8, 471–476 (2012).
Yan, T. et al. ChemBioChem 22, 1841–1851 (2021).
Hacker, S. M. et al. Nature Chem. 9, 1181–1190 (2017).
Abbasov, M. E. et al. Nature Chem. 13, 1081–1092 (2021).
Vichinsky, E. et al. N. Engl. J. Med. 381, 509–519 (2019).
Cal, P. M. S. D. et al. J. Am. Chem. Soc. 134, 10299–10305 (2012).
Akcay, G. et al. Nature Chem. Biol. 12, 931–936 (2016).
Competing Interests
The author declares no competing interests.